Close
Digital Health & Ai Innovation summit 2026
APE 2026

Elekta received approval to sell Elekta Compact in China

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Spinoff from 3M Health Care Acquires...

Solventum went ahead and shared on December 23, 2025,...

Fulgent Eyeing Bako, StrataDx for its...

Fulgent Genetics has inked a definitive agreement so as to...

Edwards Gets FDA Nod for Sapien...

In recent news, Edwards Lifesciences has gone on to win...
Elekta has received approval from the Chinese authority state Food and Drug Administration to sell its linear accelerator Elekta Compact in China.

Elekta has received approval from the Chinese authority state Food and Drug Administration to sell its linear accelerator Elekta Compact in China.

Elekta Compact is a competitive linear accelerator for high quality conventional radiotherapy, configured for countries in need of rapid build-up of additional treatment capacity. Elekta Compact is based on a combination of technology from Elekta and from the product platform developed by the Chinese company BMEI, which Elekta acquired in 2006.

Tomas Puusepp, President and CEO of Elekta says, There is a large potential for Elekta Compact in China, where there is shortage of good cancer treatment. The number of linear accelerators is less than one per million inhabitants and a large part of the existing systems needs to be replaced. Further, Elekta Compact is the ideal treatment system when replacing existing Cobalt units as the platform allows for further growth and expansion.

In May 2008 Elekta received SFDA approval to export Elekta Compact outside China and in June 2008 Elekta completed the process of adding CE marking, allowing Elekta Compact to be marketed in Europe, Latin America and Asia.

Latest stories

Related stories

Spinoff from 3M Health Care Acquires Acera Surgical

Solventum went ahead and shared on December 23, 2025,...

Fulgent Eyeing Bako, StrataDx for its Lab Services Business

Fulgent Genetics has inked a definitive agreement so as to...

Edwards Gets FDA Nod for Sapien M3 Mitral Valve Replacement System

In recent news, Edwards Lifesciences has gone on to win...

Abbott to Enter U.S. PFA Market with Volt PFA System

Abbott is soon going to enter the competitive U.S....

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »